Структура и антибактериальная активность Максаквина (ломефлоксацин гидрохлорид ) — препарата группы фторхиполопов (обзор литературы)

1. Wolfson J.S ., Hooper D.C. Fluoroquinolone antimicrobial agents / / Clin. Microbiol. R ev.— 1989.— Vol.2.— P .378— 424.

2. Neu I I.С. Quinolone antimicrobial agents / / Annu. rev. M ed.— 1992.— Vol.43.— P .465— 486.

3. Chu D .T ., Fernandes P.B. Structure-aclivity relationships of the fluoroquinolones / / Antimicrob. Agents C hem other.— 1989.— V ol.33.— P .131 — 135.

4. Hooper D.C., Wolfson J.S. Mode of action of the quinolone antim icrobial agents: review of recent information / / Rev. Infect. D is.— 1989.—'V o l.11, Suppl.5.— P .S 9 0 2 — S911.

5. Neu JI.C. Pharm acokinetics, microbiology, cost: interrelated problems for the 1990s that impact on the use of fluoroquinolone antimicrobial agents / / Am. J. M ed.— 1 9 9 2 .— V ol.92, Suppl.4A .— P .2 S — 7S.

6. Piddock L.J.V ., Jlall M .C ., Wise R. Mechanism of action of lomefloxacin / / Antimicrob. Agents Chemother.— 1990.— V ol.34.— P .1088— 1093.

7. Cozarelli N .R. DNA gyrasc and the supercoiling of DNA / / Science.— 1980.— Vol.207 — P .953— 960.

8. Geliert M . DNA lopoisomcYases / / Annu. Rev. Biochcm.— 1981.— Vol.50.— P .879— 910.

9. Liu L.F., Rowe Г.С., Yang L. et al. Cleavage of DNA by mammalian DNA topoisomerase II / / J. Biol. C hem .— 1983.— Vol.25 8 .— P. 15365— 15370.

10. Hussy P., Maas G., Tummler В . et al. Effect of 4-quinoloncs and novobiocin on calf thymus DNA polymerase primase complex, topoisomcrascs I and II, and growth of mammalian lymphoblasts / / Antimicrob. Agents. Chemother.— 1 9 8 6 .— V ol.2 9 .— P .1073— 1078.

11. IJirose Т., Okezaki E ., Kalo II. et al, In vitro and in vivo activity of N Y -198, a new difluorinated quinolone / / Ibid.— 1987.— Vol.31.— P .854— 859.

12. Okezaki E .,Ohinicfn K ., Koike S. el al. Bacteriological evaluation of NY -198 / / Chemotherapy (Tokyo).— 1988.— V ol.36, Suppl.2.— P .99— 111.

13. Jones R .N ., Aldridge K .E ., Barry A .L. et al. Multicenter in vitro evaluation of lomefloxacin (NY -198, SC -17111), including tests against nearly 7000 bacterial isolates and preliminary recommendations for susceptibility testing / / Diagn. Microbiol. Infect. Dis.— 1988.— V ol.10.— P .2 2 1 — 240.

14. Van der Auwera P., Grenier P., G lupczynsky Y., Pierard D. In-vitro activity of lomefloxacin in comparison with pefloxacin and ofloxacin / / J. Antimicrob. Chem other.— 1989.— Vol.23.'— P .2 0 9 — 219.

15. Robbins M .J., Baskerville A .J., Sanghraika M . et al. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone / / Diagn. Microbiol. Infect. Dis.— 1989.— V ol.12, Suppl.3.— P .6 5 S — 76S.

16. Cornaglia G., Ligozzi M ., Pelosi E. et al. In vitro activity of lomefloxacin (SC -47111) against E nlerobacteriaceae enterococci and staphylococci / / J. C hem other.— 1989.— V o l.l.— P .81 — 90.

17. Rossolini G.M ., Valentini S., Satta G. Evaluation of in vitro antim icrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacleriaccae, and Pseudom onas aeruginosa / / D iagn. Microbiol. Infect. Dis.— 1989.— V ol.12, Suppl.3.— P.5 7 S — 64S.

18. Molinari G., Bandclloni R., Paglia P. et al. In vitro antimicrobial activity and postantibiotics effect of lomefloxacin, a new difluoro quinolone / / Ibid.— P .5 3 S — 56S.

19. Lewin C .S., Amyes S.G .B ., Smith G.T. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL 16 / / Eur. J. Clin. Microbiol. Infect. Dis.— 1989.— Vol.8 .— P .731— 733.

20. Chin N .X ., N ovelli A ., Neu I I.C. In vitro activity of lomefloxacin (SC -17111, N Y -198), a difluoroquinolone 3— carboxylic acid, com pared with those of o ther quinolones / / Antimicrob. Agents Chem other.— 1988.— Vol.3 2 .— P .656— 662.

21. Nishino T., Obana Y., Tanino T. In vitro andin vivo antibacterial activities of H Y -198, anew fluoroquinolone / / Chem otherapy (T okyo).— 1988.— Vol.36, Suppl.2.— P .5 7 — 74.

22. Wise R ., Andrews J.M ., Ashby J.P ., Matthews R .S. In vitro activity of lomefloxacin, a new quinolone antim icrobial agent, in comparison with those of older agents / / Antimicrob. Agents Chemother.— 1988.— Vol.3 2.— P .617— 622.

23. Shah P .M , Muller S.', Kipp J., Stille W. In vitro activity of lomefloxacin (N Y -198 or S C -4 7 1 1 1 ) / / D iagn. Microbiol. Infect. Dis. _ 1989.— V ol.12, Suppl.3.— P .9 7 S — 101S.

24. Edwards R ., Kanematsu M ., Greenwood D. Laboratory assessment of lomefloxacin (SC -47111) in comparison with norfloxacin / / J. Antimicrob. C hem other.— 1988.— Vol.2 2.— P .885— 890.

25. Sonstein S .A ., Dahlgren J. In vitro activity of lomefloxacin (SC-47111 or N Y -198), a new quinolone antim icrobial against clinical isolates of common pathogens / / Diagn. Microbiol. Infect. D is.— 1989.— V ol.12, Suppl.3.— P .2 1 S — 28S.

26. Aldridge K .E ., Ilenderberg A ., Sanders C.V. Lomefloxacin (SC47111 or N Y -198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antim icrobials against E nlerobacteriaceae, A cinetobacter spp. Aeromonas spp. and Pseudom onas Aeruginosa / / Ib id .— P .I S — 6S.

27. Stratton C.W ., Weeks L.S. Bactericidal activity of lomefloxacin S C -4 7 111 (N Y -198) and ciprofloxacin against selected pathogens / / Ibid.— P .2 9 S — 34S.

28. Wadworth A .N ., Goa K.L. Lom efloxacin. A review of its antibacterial activity. Pharm acokinetic properties and therapeutic use / / Drugs.— 1991.— V ol.42.— P .1018— 1060.

29. Burnham J .S ., Sonstein S .A . Anti-virulence effects of lomefloxacin and other quinolones / / Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy .— Washington : American Society for Microbiology, 1990.— Abstract 1010.

30. Pruul II., McDonald P.J. Lom efloxacin-induced modification of the kinetics of growth of gram -negative bacteria and susceptibility to phagocytic killing by human neutrophils / / J. Antimicrob. C hem other.— 1990.— V ol.25.— P .91— 101.

31. Debbia E .A ., Pescc A ., Schito G.C. In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram -negative pathogens / / Am. J. M ed.— 1992.— Vol.92, Suppl.4A .— P .4 5 S — 47S.

32. Saharkhiz-Langroodi A ., Renk C.M . Effect of subminimal inhibitory concentrations of lomefloxacin (NY -198, SC -47111) on phagocytosis of Staphylococcus aureus by human polym orphonuclear leukocytes / / Abstracts of the 89th Annual Meeting of the American Society for Microbiology.— Washington: American Societv for Microbiology, 1989.— P. 104.— A bstract D 134.

33. Goto S., Ogawa M ., Kaneko Y., Kuwahcira S. In vitro and in vivo antibacterial activity of H Y -198, a new pyridone carboxylic acid derivative / / Chemotherapy (Tokyo ).— 19 8 8 .— V ol.36, Suppl.2.— P .36— 56.

34. Aldridge K .E , Ilenderberg A ., Gebbia K. et al. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antim icrobial spectrum , potency, and development of resistance / / Diagn. Microbiol. Infect. D is.— 1989.— Vol. 12.— P .2 2 1 — 233.

35. Rüstige C., Wiedem ann B. Antibacterial activity of lomefloxacin in a pharm acokinetic in vitro model / / Antimicrob. Agents C hem other.— 1990.— .V ol.34.— P .1107— 1111.

36. Weinstein M .P. Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganism scausing bacterem ia / / Diagn. Microbiol. Infect. Dis.— 1988.— Vol. 11.— P. 195— 200.

37. Wright D.N., Saxon B., Matsen J.M . Comparative in vitro activity of lomefloxacin (SC-47111 or NY-198) against fresh clinical bacterial isolates / / Ibid.— 1989.— Vol. 12, Suppl.3.— P .7 S — 1 IS.

38. Jnderlied C.B. Lancero M .G ., Berm udez E M ., Young E S . In vitro activity of lomefloxacin as compared with ciprofloxacin / / Ibid.— P.17S— 20S.

39. Finch R., M artin J., P ilkington R. In-vitro assessment of lomefloxacin (SC -47111)— a new quinolonc derivative /7 J. Antimicrobe. Chem olher.— 1988.— Vol.2 2.— P .881— 884.

40. Sun Z .M ., Maskell J.P ., Sehgal S .C., W illiams J.D. In-vitro activity of lomefloxacin (SC -47111) and other quinolones / / Infection.— 1989.— V ol.17.— P .165— 167.

41. Holt II.A ., Bywater M .J., R eeves D.S. Comparative in vitro activity of lomefloxacin and other agents against clinical bacterial isolates / / Rev. Infect. Dis.— 1989.— Vol. 11, Suppl 5 .— P .S 933— S934.

42. Ross P.W . Antibacterial activity of lomefloxacin / / Ibid.— P.S936.

43. Clarke A .M ., Zemcov S.J.V. Comparative in vitro activity of lomefloxacin, a new difluoroquinolone / / Eur. J. Clin. Microbiol. Infect. Dis.— 1989.— Vol.8 .— P .164— 168.

44. Hohan D., Grabowski M ., K oss J., Weselowski V. Lomefloxacin, a new difluoroquinolone in vitro activity against gram-positive and gram -negative bacteria / / Diagn. Microbiol. Infect. Dis.— 1989.— V ol.12, Suppl.3.— P .7 7 S — 82S.

45. Dubois J., St-Pierre C. Antibacterial activity of lomefloxacin against urinary .tract, gastrointestinal tract, and respiratory tract pathogens / / Curr. Ther. R es.— 1989.— Vol.45.— P. 1000— 1005.

46. Dette G.A., Knothe II. In vitro evaluation of lomefloxacin / / Arzeim .— Forsch.Drug R es.— 1989.— Vol.39.— P .832— 835.

47. Soussy C.J., Le Van Thoi J., Morel C. et al. In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a m ulticenter study / / Pathol. Biol. (P aris).— 1990.— Vol.3 8.— P .390— 396.

48. Derlot E ., Poyart-Salmcron C., Courvalin P. Antibacterial and plasmid curing activity of lomefloxacin in vitro / / E ur. J. Clin. Microbiol. Infect. Dis.— 1989.— Vol.8 .— P .1048— 1052.

49. Duraso P., Resano P., Gonzalez M .A . Lomefloxacin (SC-47111 or N T -198). Com parative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City / / Diagn. Microbiol Infect. Dis.— 1990.— Vol. 13.— P .7 1 — 75.

50. MagalhaesM ., TrabulsiL .R ., Montelli A.C. Lomefloxacin activity against 2813 clinical isolates: a collaborative study at three medical centers in Brazil / / Ibid.— 1989.— Vol. 12, Suppl.3.— P .35S— 39S.

51. Mimica I. In vitro assessment of lomefloxacin against grampositive and gram -negative pathogens in Brazil / / Rev. Bras. M ed.— 1992.— V ol.49.— P .5 6 8 — 570.

52. Torres J.R. Antimicrobial activity of lomefloxacin (NY-198, SC -47111) against bacterial strains from Venezuela / / Diagn. Microbiol. Infect. Dis.— 1989.— Vol. 12, Suppl.3.— P .4 1 S — 43S.

53. Bianchini II.N ., Sarachian B., Fernandez A. et al. A tenlaboratory study of lomefloxacin (N Y -198 or SC -47111) antimicrobial activity in Argentina / / Ibid.— P .4 5 S — 50S.

54. Trujillo II., Mejia de R .G .I., Castrillon de P.L., Gomez C. In vitro evaluation of lomefloxacin activity in Colombia / / Ibid.— P .5 IS — 52S.

55. Lal.itha M .K ., N isha A .K ., Bhattacharya S.S. et al. Susceptibility pattern of bacterial isolates to lomefloxacin / / Indian J. Med. R es.— 1990.— Vol.91.— P .182— 184.

56. DiVincenzo C .A., Shatzer K .L., Venezio F.R. In vitro activity of lomefloxacin against multiply resistant Pseudom onas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis / / Diagn. Microbiol. Infect. Dis.— 1989.— V ol.12, Suppl.3.— P .1 3 S — 16S.

57. Verbist L., Jacobs J. In vitro activity of lomefloxacin against multiresistant clinical bacterial isolates / / Rev. Infect. Dis.— 1989.— V o l.ll, Suppl.5 .— P.S929.

58. Forward K .R ., Degagne P.A ., Bartlett K .R. The comparative activity of lmefloxacin (SC -47111, NY-198) and other orally absorbable agents against Haemophilus in fluenzae and Branham ella catarrhalis / / Diagn. Microbiol. Infect. Dis.— 1989,— V ol.12.— P .437— 440.

59. Kohno S., Yamaguchi K., Dohtsu Y. et al. Efficacy of N Y -198 against experim ental Ledionnaires Disease / / Antimicrob. Agents Chem olher.— 1988.— V ol.32.— P. 1427— 1429.

60. E delstein P .II., G audet E .A ., E delstein M .A .C . In vitro activity of lom eflo x acin (N Y -1 9 8 o r S C -4 7 1 1 1 ), c ip ro flo x ac in , erythrom ycin against 100 clinical Legionella strains / / Diagn. Microbiol. Infect. D is.— 1989.— Vol. 12, Suppl.3.— P.93S— 95S.

61. Dubois J., Jol.y J.R . In vitro activity of lomefloxacin (S C -47111, N Y -198) against isolates of Legionella spp / / Ibid.— P.89S— 91 S.

62. Lind/i E ., Dornbush K., Jalakas K., Porsgren A. Antibiotic susceptibility and -lactam ase production in clinical isolates of Enterobacter spp. / / APM IS.— 1990.— Vol.9 8.— P .462 — 470.

63. Qadri S.M .JI., A l-Sedairy S., Ueno Y. Antibacterial activity of lomefloxacin against Brucella melitensis / / Diagn. Microbiol. Infect. Dis.— 1990.— Vol. 13.— P .2 7 7 — 279.

64. Maeda II., Pujii A ., Nakata K. et al. In vitro activities of T-3262, NY -198, fleroxacin (AM -833, R O -2 3-6240), and other quinolone agents against clinically isolated Chlam ydia trachom atis strains / / Antimicrob. Agents Chemothcr.— 1 9 8 8 .— V o l.3 2 .— P .1080— 1081.

65. Iloban D., DeGagne P., Witwicki E. In vitro activity of lome floxacin against Chlamydia trachomatis , Neisseria gonorrhocae, Haem ophilus ducreyi, micoplasma hominis, and U reaplasm a urealyticum / / Diagn. Microbiol. Infect. Dis.— 1989.— V ol.12, Suppl.3.— P.83S— 86S.

66. Orfila J., Haider P. Comparative study of the in vitro activity of lomefloxacin versus lomefloxacin combined with metronidazole versus lomefloxacin in combination with amoxicillin clavulanic acid against Chlamidia trachom atis / / Int. J. Antimicrob. Agents.— 1992.— Vol.2.— P .11 — 14.

67. Talbot II., Romanowski B. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhocae and Chlam ydia trachom atis / / Antimicrob. Agents Chem olher.— 1989.— Vol.33.— P .2049— 2051.

68. Vander Willigen A .II., Degener J.E ., Vogel M . et al. In vitro activities of seven guinolone derivatives against N eisseria gonorrhocae / / Arzneim -Forsch. Drug Res.— 1990.— Vol.40.— P .684— 685.

69. Nagayam a A., Nakao T., Tcien II. In vitro activities of ofloxacin and four other new quinolone-carboxylic acids against Chlam ydia trachom atis / / Antimicrob. Agents Chemolher.— 1988.— V ol.32.— P .1735— 1737.

70. Sergeii J., Kessler II.A , Kapell K., Trcnholmc G.M. In vitro activity of lom efloxacin (S C -47111 o r N Y -198) against Chlamydia tranchomatis strains / / Diagn. Microbiol. Infect. Dis.— 1989.— V ol.12, Suppl.3.— P.87S— 88S.

71. Kenny G.E., Hooton T.M ., Roberts M .C . et al. Susceptibilities of genital mycoplasmas to the newer quinolones as determ ined by the ag ar dilution method / / Antimicrob. Agents Chemolher.— 1989.— Vol.33.— P .103— 107.

72. Cassell G .IL, Waites K .B., Pate M .S. et al. Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin / / Diagn. Microbiol. Infect. Dis.— 1989.— V ol.12.— P .433— 435.

73. Renaudin H ., Bebear C. Com parative in vitro activity of azithrom ycin, clarithrom ycin, erythrom ycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and U reaplasm a urealyticum / / E ur. J. Clin. Microbiol. Infect. Dis.— 1990.— Vol.9.— P. 838— 841.

74. Simor A .E ., Ferro S., Low’ D .E. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori / / Antimicrob . Agents Chemolher.— 1989.— Vol.33.— P .108— 109.

75. Segreii J., N elson J.A ., Goodm an L.J. et al. In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea / / Ibid.— P .1385— 1387.

76. Felmingham D., Robbins M .J. In vitro activity of lomefloxacin and other antimicrobial against bacterial enteritis pathogens / / Diagn. Microbiol. Infect. Dis.— 1992.— V ol.15.— P .339— 343.

77. Carrillo C., Tolm os J., Adachi J. et al. In vitro antimicrobial susceptibility testing of 319 toxigenic Vibrio cholerae 0 1 ,E l Tor, strains isolated during the cholera outbreak in Peru, comparing with 204 isolates of Shigella sp. //Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotheraphy .— Washington : American society for Microbiology, 1992.— P .2 42.— Abstract 793. '

78. 8 Danerjee D.K., Ford J .t Markanday S. In-vitro activity of lomefloxacin against pathogenic and environm ental mycobacteria / / J. Antimicrob. Chem other.— 1992.— Vol.30— P .236— 238.

79. Piersimoni C., M orbiducci V., Boniigia S. et al. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis / / Am. Rev. Rcspir. Dis.— 1992.— Vol. 146.— P .1 4 4 5 — 1447.

80. Mayer K .H ., Ella l J.A . Lomefloxacin microbiologie assessment and unique properties / / Am. J. M ed.— 1992.— Vol.92, Suppl.4A .— P .5 8 S — 52S.

81. W olfson J.S ., H ooper D.C. Bacterial resistance to quinolones: mechanism s and clinical im portance / / Rev. Infect. D is.— 1989.— V ol.11, Suppl.5.— P .S 9 6 0 — S968.

82. Damn T .E ., Schaberg D .R ., Terpenning M .S . et al. Increasing resistance of Staphylococcus aureus to ciprofloxacin / / Antimicrob. Agents Chemother.— 1990.— Vol.34.— P. 1862— 1863.

83. Scliaefler S. Metchicillin-resistant strains of Staphylococcus aureus resistant to quinolones / / J. Clin. M icrobiol.— 1989.— Vol.27.— P .3 3 5 — 336.

84. Dcbbia E ., Paglia P., Bandelloni R. et al. In vitro interactions between lomefloxacin, a new quinolone, and other drugs / / Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotheraphy.— Washington: American Society for Microbiology, 19 8 8 .— P .l 18.— Abstract 49.

85. Stratton C.W. Evaluation of the effect (indifferent, additive, synergistic, or antagonistic) of lomefloxacin on the bactericidal activity of metronidazole against selected anaetobic bacteria as determined by time-kill kinetic methodology / / Abstracts of the 16th International Congress of Chemotherapy.— Jerusalem , 1989.— P .302.

86. Aldridge K .E ., Ilenderberg A ., Sanders C.V. Mutational frequency of gram -positive and gram -negative bacteria to resistance to lomefloxacin and other quinolones / / Rev. Infect. Dis.— 1989.— V ol.11, Suppl.5.— P .S 9 7 4 — S975.

87. Paglia P., Bandelloni R ., Molinari G. et al. Effect of lomefloxacin on m aintenance and transfer of episome El 04 / / Ibid.— P .S 9 7 3 — S974.

88. Jones R .N . Fluoroquinolone (lom efloxacin) international surveillance trial: a report of 30 months of monitoring in vitro activity / / Am. J. M ed.— 1992.— Vol.92, Suppl.4A .— P .5 2 S -- 57S.

89. Jones R .N . Fluoroquinolone resistance. An evolving national problem or just aproblcm for some physicians? / / Diagn. Microbiol. Infect. Dis.— 1992.— V o l.15.— P .177— 179.

90. De Mouy D. Fluoroquinolone resistance in the hospital versus outpatients setting / / Int. J. Antimicrob. Agents.— 1992.— Vol.2.— P .15— 18.

91. Trucksis M ., Hoopcr D .C ., Wolfson J.S . Emerging resistance to fluoroquinolones in staphylococci: an alert (editorial) / / Ann. Intern. Med.— 1991.— V ol.114.— P .424— 426.

92. Miwa H ., Nakashiinizu II., Ilori K. el al. In vivo antibacterial activity of N Y -198 / / Chem otherapy (T okyo).— 1988.— Vol.36, Suppl.2.— P. 112— 119.

93. Gerard A ., Chambers II.F. T reatm ent of methiciclin-resistant Staphylococcus aureus aortic valve endocarditis in rabbits with lomefloxacin //P rograms and Abstracts of the Twenty-Ninth Intersciencc Conference on Antimicrobial Agents and Chemotherapy .— Washington : American Societyfor Microbiology, 1989.— P .267.— Abstract 972.

94. Butler Т., Cartagenova M ., Dunn D. Treatm ent of experimental Salmonella typhimurium infection in mice with lomefloxacin III. Antimicrob. Chem other.— 1990.— Vol.25.— P .629— 634.

95. Gerard. A ., Chambers I I.F., Sande M .A . et al. Treatment of methicillin -resistant Staphylococcus aureus aortic valve endocarditis in rabbits with lomefloxacin / / Ann. Med. N ancy.— 1992.— Vol.31.— P .l 97— 199.

96. Gelber R .H ., Iranmancsh A ., Murray L. cl al. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice / / Antimicrob. Agents Chemother.— 1992.— Vol.3 6.— P.2 5 4 4 — 2547.

97. Fernandes P.B., Swanson R .N . Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies / / Drugs Exp. Clin. Res.— 1988.— Vol. 14.— P .375— 378.

98. Drusano G.L., Johnson D .E ., Rosen M ., Standiford II. C. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis / / Antimicrob. Agents Chem other.— 1993.— Vol.3 7.— P .483— 490.